SANOFICONR · NSE
Sanofi Consumer Healthcare India Limited
₹4,033.4
+1.10% (+₹43.9)
Prev. close
₹3,989.5
Volume
4,359
Delivery %
65.0%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.
Details
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Himanshu Bakshi
Headquarters
Mumbai
Employees
597
Exchange
View on NSE ↗Key stats
Market cap
₹9,262.76 Cr
P/E ratio (TTM)
34.8
Dividend yield
1.88%
EPS (TTM)
₹115.32
Beta (1Y · daily vs NIFTY 50)
0.50
Shares float
65.74 L
EPS · quarter ended Jun 2026
₹29.87
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: January–December (calendar year — this company reports on a December year-end), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| ₹544.30 Cr | ₹724.50 Cr | ₹878.40 Cr | |
| EBITDA | ₹221.30 Cr | ₹255.20 Cr | ₹334.00 Cr |
| ₹164.90 Cr | ₹181.00 Cr | ₹240.10 Cr | |
| Diluted EPS | ₹71.6 | ₹78.59 | ₹104.27 |
Total expenses (as filed), Employee benefit expense, Other expenses, Other income have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| ₹345.40 Cr | ₹431.30 Cr | ₹547.00 Cr | |
| ₹0 | ₹20.30 Cr | ₹24.80 Cr | |
| Stockholders' equity | ₹207.60 Cr | ₹273.00 Cr | ₹384.00 Cr |
CWIP, Others, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| ₹-40.00 L | ₹439.00 Cr | ₹174.80 Cr | |
| Investing cash flow | ₹0 | ₹1.90 Cr | ₹-7.60 Cr |
| ₹2.00 Cr | ₹-115.60 Cr | ₹-134.50 Cr | |
| Capital expenditure | ₹-4.00 Cr | ₹-9.90 Cr | ₹-7.60 Cr |
| End cash position | ₹1.60 Cr | ₹326.90 Cr | ₹374.80 Cr |
Dividends paid has filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 24–Mar 25(5Q) | Jun 25–Jun 26(5Q) |
|---|---|---|
| Promoter | 60.40% | 71.27% |
| Public | 39.60% | 28.73% |
| Employee trusts | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| Sanofi Consumer Healthcare India Limited | ₹9,294.59 Cr | ₹3,989.5 | 34.9 | 24.20 | 62.5% | 0.06 | +22.6% | -24.3% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Concall transcripts
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
9 indices
NSE weights are a free-float market-cap-share estimate, not NSE’s own published (and sometimes capped) index weight. BSE weights are BSE’s own published index weight, not an estimate. Indices without weight data are listed without one, in alphabetical order after the weighted ones.
Sanofi Consumer Healthcare India Share Price Hits Fresh 52-Week Low at Rs 3,969: Key Reasons Behind the Fall
Univest · 2 days ago